mitazalimab
Alligator Biosciences vd om emissionen
Alligator Bioscience utvecklar tumörriktade antikroppsbaserade behandlingar mot cancer. I början av året rapporterade bolaget positiva interimsresultat från OPTIMIZE-1, fas...
BioStock Investor Pitch: Alligator Bioscience
Alligator Bioscience har fått en bra start på...
FDA godkänner Alligators fas II-studie
Alligator BioScience fortsätter att göra framsteg med sin...
Alligator’s CMO hosts in-depth webinar on Mitazalimab
At the beginning of the year, Alligator BioScience...
Alligator Bioscience extends collaboration with Orion Corporation
As Alligator Bioscience makes headways with its clinical...
Alligator Bioscience presents positive interim data
Alligator Bioscience's CEO Søren Bregenholt visited BioStock’s studio...
Alligator Bioscience is ready for an exciting news flow
A lot is going on at Alligator Bioscience....
Alligator Bioscience’s new CMO
Lund-based Alligator Bioscience has several projects in its...
Alligator Bioscience’s CEO looks ahead
Recently, Lund-based Alligator Bioscience delivered its report for...
BioStock Studio: Alligator Bioscience’s CEO on the latest data
Lund-based biotech company Alligator Bioscience recently announced safety...
Allegro Investment Fund about the ownership in Alligator Bioscience
Recently, Allegro Investment Fund exceeded the 25 percent...
Alligator Bioscience on the latest developments
Only a few weeks into the new year...
